Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of 2,5-diarylnicotinamides as selective orexin-2 receptor antagonists (2-SORAs)
Swati P. Mercer, Anthony J. Roecker, Susan L. Garson, et al.
Bioorganic & Medicinal Chemistry Letters (2013) Vol. 23, Iss. 24, pp. 6620-6624
Closed Access | Times Cited: 24

Showing 24 citing articles:

Orexin Receptor Antagonists: New Therapeutic Agents for the Treatment of Insomnia
Anthony J. Roecker, Christopher D. Cox, Paul J. Coleman
Journal of Medicinal Chemistry (2015) Vol. 59, Iss. 2, pp. 504-530
Closed Access | Times Cited: 107
The Hypocretin/Orexin System: An Increasingly Important Role in Neuropsychiatry
Quanhui Chen, Luı́s de Lecea, Zhian Hu, et al.
Medicinal Research Reviews (2014) Vol. 35, Iss. 1, pp. 152-197
Closed Access | Times Cited: 79
Recent trends in orexin research—2010 to 2015
Christoph Boss, Catherine Roch
Bioorganic & Medicinal Chemistry Letters (2015) Vol. 25, Iss. 15, pp. 2875-2887
Closed Access | Times Cited: 74
Characterization of JNJ-42847922, a Selective Orexin-2 Receptor Antagonist, as a Clinical Candidate for the Treatment of Insomnia
Pascal Bonaventure, Jonathan Shelton, Sujin Yun, et al.
Journal of Pharmacology and Experimental Therapeutics (2015) Vol. 354, Iss. 3, pp. 471-482
Open Access | Times Cited: 71
Discovery of 5′′‐Chloro‐N‐[(5,6‐dimethoxypyridin‐2‐yl)methyl]‐2,2′:5′,3′′‐terpyridine‐3′‐carboxamide (MK‐1064): A Selective Orexin 2 Receptor Antagonist (2‐SORA) for the Treatment of Insomnia
Anthony J. Roecker, Swati P. Mercer, John D. Schreier, et al.
ChemMedChem (2013) Vol. 9, Iss. 2, pp. 311-322
Closed Access | Times Cited: 62
Structure–Activity Relationship, Biological, and Pharmacological Characterization of the Proline Sulfonamide ACT‐462206: a Potent, Brain‐Penetrant Dual Orexin 1/Orexin 2 Receptor Antagonist
Christoph Boss, Catherine Roch‐Brisbare, Michel A. Steiner, et al.
ChemMedChem (2014) Vol. 9, Iss. 11, pp. 2486-2496
Closed Access | Times Cited: 38
Selective orexin 2 receptor antagonism blocks cue-induced reinstatement, but not nicotine self-administration or nicotine-induced reinstatement
Jason M. Uslaner, Christopher J. Winrow, Anthony L. Gotter, et al.
Behavioural Brain Research (2014) Vol. 269, pp. 61-65
Closed Access | Times Cited: 35
Orexin OX2 Receptor Antagonists as Sleep Aids
Laura H. Jacobson, Sui Chen, Sanjida Mir, et al.
Current topics in behavioral neurosciences (2016), pp. 105-136
Open Access | Times Cited: 35
Optical probing of orexin/hypocretin receptor antagonists
Shi‐Bin Li, Natalie Nevárez, William J. Giardino, et al.
SLEEP (2018) Vol. 41, Iss. 10
Open Access | Times Cited: 32
Substituted pyrrolidin-2-ones: Centrally acting orexin receptor antagonists promoting sleep. Part 2
Thierry Sifferlen, Amandine Boller, Audrey Chardonneau, et al.
Bioorganic & Medicinal Chemistry Letters (2015) Vol. 25, Iss. 9, pp. 1884-1891
Closed Access | Times Cited: 31
Discovery of MK-3697: A selective orexin 2 receptor antagonist (2-SORA) for the treatment of insomnia
Anthony J. Roecker, Thomas S. Reger, M. Christa Mattern, et al.
Bioorganic & Medicinal Chemistry Letters (2014) Vol. 24, Iss. 20, pp. 4884-4890
Closed Access | Times Cited: 28
Access to pyridines via cascade nucleophilic addition reaction of 1,2,3-triazines with activated ketones or acetonitriles
Yuan Zhang, Han Luo, Qixing Lu, et al.
Chinese Chemical Letters (2020) Vol. 32, Iss. 1, pp. 393-396
Closed Access | Times Cited: 19
Identification of MK-8133: An orexin-2 selective receptor antagonist with favorable development properties
Scott D. Kuduk, Jason W. Skudlarek, Christina N. DiMarco, et al.
Bioorganic & Medicinal Chemistry Letters (2015) Vol. 25, Iss. 12, pp. 2488-2492
Closed Access | Times Cited: 18
Discovery of diazepane amide DORAs and 2-SORAs enabled by exploration of isosteric quinazoline replacements
Anthony J. Roecker, Swati P. Mercer, Jeffrey M. Bergman, et al.
Bioorganic & Medicinal Chemistry Letters (2015) Vol. 25, Iss. 21, pp. 4992-4999
Closed Access | Times Cited: 16
The distribution of hypocretin/orexin receptor mRNA in the mouse and human brain
Sanjida Mir, Ryan J. Keenan, Romke Bron, et al.
Medicine in Drug Discovery (2024) Vol. 24, pp. 100202-100202
Open Access | Times Cited: 1
Small-molecule Antagonists of the Orexin Receptors
J.A. Christopher
Pharmaceutical Patent Analyst (2014) Vol. 3, Iss. 6, pp. 625-638
Closed Access | Times Cited: 12
Discovery and optimisation of 1-acyl-2-benzylpyrrolidines as potent dual orexin receptor antagonists
Jodi T. Williams, John Gatfield, Catherine Roch, et al.
MedChemComm (2015) Vol. 6, Iss. 6, pp. 1054-1064
Closed Access | Times Cited: 9
Quantitative Proteomics in Laser Capture Microdissected Sleep Nuclei From Rat Brain
Ronald Miller, Christopher J. Winrow, Daniel S. Spellman, et al.
Journal of Neurogenetics (2014) Vol. 28, Iss. 1-2, pp. 136-145
Open Access | Times Cited: 8
Investigation of orexin-2 selective receptor antagonists: Structural modifications resulting in dual orexin receptor antagonists
Jason W. Skudlarek, Christina N. DiMarco, Kerim Babaoglu, et al.
Bioorganic & Medicinal Chemistry Letters (2017) Vol. 27, Iss. 6, pp. 1364-1370
Closed Access | Times Cited: 8
Synthesis and characterization of a novel 18F-labeled 2,5-diarylnicotinamide derivative targeting orexin 2 receptor
Hiroyuki Watanabe, Naoki Matsushita, Yoichi Shimizu, et al.
MedChemComm (2019) Vol. 10, Iss. 12, pp. 2126-2130
Open Access | Times Cited: 7
Pyrazole derivatives as selective orexin-2 receptor antagonists (2-SORA): synthesis, structure–activity–relationship, and sleep-promoting properties in rats
Christine Brotschi, Martin H. Bolli, John Gatfield, et al.
RSC Medicinal Chemistry (2023) Vol. 15, Iss. 1, pp. 344-354
Closed Access | Times Cited: 2
Pharmacological evaluation of orexin receptor antagonists in preclinical animal models of pain
Terrence P. McDonald, Hongyu Annie Liang, Raul Sanoja, et al.
Journal of Neurogenetics (2016) Vol. 30, Iss. 1, pp. 32-41
Closed Access | Times Cited: 4
Orexin Receptor Antagonists
Brock T. Shireman, Michael A. Letavic
Elsevier eBooks (2016), pp. 225-279
Closed Access | Times Cited: 1
Combinatorial Chemistry Online Volume 16, Issue 2, February 2014
N.K. Terrett
Combinatorial Chemistry - an Online Journal (2014) Vol. 16, Iss. 2, pp. 5-7
Open Access
Page 1

Scroll to top